Financials and Filings

MGEN $0.92 $ - 0.01 (1.08%)

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
10-Q 10-Q 8/8/2019 6/30/2019
8-K 8-K 8/7/2019 8/7/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Termination of a Material Definitive Agreement; Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; and Financial Statements and Exhibits.
8-K 8-K 7/19/2019 7/19/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
8-K 8-K 6/21/2019 6/20/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Submission of Matters to a Vote of Security Holder.
8-K 8-K 5/21/2019 5/21/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
10-Q 10-Q 5/9/2019 3/31/2019
8-K 8-K 5/8/2019 5/8/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
Proxy DEF 14A 5/3/2019 6/19/2019
Proxy DEFA14A 5/3/2019
8-K 8-K 4/29/2019 4/29/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 4/26/2019 4/26/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
10-K 10-K 3/14/2019 12/31/2018
Registration Statement S-8 3/14/2019
8-K 8-K 3/13/2019 3/13/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 2/8/2019 2/8/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
8-K 8-K 1/24/2019 1/24/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Entry into a Material Definitive Agreement.
8-K 8-K 1/10/2019 1/10/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
13-D SC 13G 1/3/2019
8-K 8-K 12/20/2018 12/20/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 12/6/2018 12/4/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Other Events; and Financial Statements and Exhibits.

Displaying 1 to 20 (of 204 filings)